Breast-Gynecological International Cancer Society

Starts:  Jan 18, 2018 12:00 AM (EET)
Ends:  Jan 19, 2018 12:00 AM (EET)

This program has already taken place.

The 10th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC), 2018 Scientific Program was designed to give a good platform for the exchange of experience on cancers and to outline the actual status of the problems relating to the Breast and Gynecological cancers, with discussion of the prospects in the context of the most recent international trends and initiatives for the treatment.

SITC Speakers at the Conference:

Leisha Emens, MD, PhD - Johns Hopkins University
Neal Ready, MD, PhD - Duke University Medical Center

The Conference was organized by the BGICS, in collaboration with the Society for Immunotherapy of Cancer (SITC). BGICS is a non-profit society aiming at promoting optimal standards of care for patients with breast and gynecological cancers.

The 10th BGIICC was held January 18-19, 2018 in Cairo, Egypt.


Session Agenda

January 18, 2018
The 2nd Wave Immunotherapy Tsunami Session

2:00 – 2:20 p.m.

1st BGICS-SITC Clinical Practice Recommendation in Immune-Oncology
Hesham El Ghazaly, MD – Alfa Cure Center

2:20 – 2:35 p.m.

Biomarkers Beyond PDL-1 for Immune-Therapy: TILs, TMB and others: The Way for Patients’ Selection
Christian Rolfo, MD, PhD, MDAh – University of Antwerp

2:35 – 2:50 p.m.

Solving the Hard Question in IO: Sequencing Versus Combination, Timing, and Duration
Neal E. Ready, MD, PhD – Duke University Medical Center

2:50 – 3:05 p.m.

Potential Role of Immune-Therapy in the Pre-Metastatic Setting
Leisha Emens, MD, PhD – Johns Hopkins University

3:05 – 3:25 p.m.

Combination Immune-Therapy: The Rationale and Outcomes
Moshen Mokhtar, MD – Cairo University, Center of Radiation Oncology and Nuclear Medicine

3:25 – 3:45 p.m.

Immunotherapy in Lung Cancer: The Full Story
Neal E. Ready, MD, PhD – Duke University Medical Center

3:45 – 4:05 p.m.

Driving Mutations in Lung Cancer: Hitting the New and Old Targets and Immunotherapy Role
Christian Rolfo, MD, PhD, MDAh – University of Antwerp



#2018
#Biomarkers
#ClinicalTrials
#BoneCancers
#BrainCancers
#BreastCancers
#ColorectalCancer
#GastrointestinalCancers
#GenitourinaryCancers
#HeadandNeckCancers
#HematologicMalignancies
#LungCancers
#SkinCancers
#Article
#InPersonEvent
#Collaboration
#CollaborativeEvent
#Adverse Events
#Cellular Therapies
#ImmuneCheckpointInhibitors
#Toxicities
#Clinician
#Oncologist
#Researcher

Location

Fairmont Towers Heliopolis
El-Orouba, Qism El-Nozha
Cairo Governorate, 11736